Psy18 a Decision Analysis Model Exploring the Results of a Phase Ii Trial of Eltrombopag for Patients With Chronic Hepatitis C, Cirrhosis and Thrombocytopenia

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.02.351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis

New England Journal of Medicine
Medicine
2000English

Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2016English

Variables Associated With Cirrhosis Diagnosis in Patients With Chronic Hepatitis C: A Case-Control Study

Health
2015English

Prospects for the Treatment of Patients With Chronic Viral Hepatitis With Cirrhosis

Vestnik of Saint Petersburg University. Medicine
2018English

Daclatasvir and Sofosbuvir With Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients With Cirrhosis: A Phase III Study (ALLY-3C)

Antiviral Therapy
Infectious DiseasesPharmacology
2018English

Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study

American Journal of Gastroenterology
HepatologyGastroenterology
2015English

Recurrent Coronary Thrombus in a Patient With Chronic Immune Thrombocytopenia With Treatment Using Eltrombopag

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2019English

Effects of Dietary Iron Reduction Versus Phlebotomy in Patients With Chronic Hepatitis C: Results From a Randomized, Controlled Trial on 40 Japanese Patients

Internal Medicine
Internal MedicineMedicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy